In conclusion, our findings highlight the pivotal role of WBP5 in the initiation and progression of HNSCC, positioning it as a key biomarker and therapeutic target for regulating cancer cell proliferation and immune evasion. The gene discussed is TCEAL9; the disease is cancer.